BIOSTAR TECHNOLOGIES
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.
BIOSTAR TECHNOLOGIES
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2002-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.biostar-pharm.com
Total Employee:
11+
Status:
Active
Contact:
010-56315388
Email Addresses:
[email protected]
Total Funding:
890 M USD
Technology used in webpage:
Nginx DigiCert SSL Encryption Everywhere Alibaba CNDNS Orange IT
Investors List
CCB International
CCB International investment in Series E - Biostar Technologies
Sinopharm Capital
Sinopharm Capital investment in Series E - Biostar Technologies
Matrix Partners China
Matrix Partners China investment in Series E - Biostar Technologies
Tianchuang Capital
Tianchuang Capital investment in Series E - Biostar Technologies
EFung Capital
EFung Capital investment in Series E - Biostar Technologies
Chengdu Biocity
Chengdu Biocity investment in Series E - Biostar Technologies
Tianjin Venture Capital
Tianjin Venture Capital investment in Venture Round - Biostar Technologies
Chengdu Venture Capital
Chengdu Venture Capital investment in Series B - Biostar Technologies
DT Capital Partners
DT Capital Partners investment in Series B - Biostar Technologies
SDIC Venture Capital
SDIC Venture Capital investment in Series B - Biostar Technologies
Official Site Inspections
http://www.biostar-pharm.com
- Host name: 47.116.187.136
- IP address: 47.116.187.136
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Biostar Technologies"
北京华昊中天生物医药股份有限公司
华昊中天成立于2002年，2024年在香港主板上市（股票代码：2563.hk）。依托先进且可持续的合成生物学新药研发平台，专注于开发具有自主知识产权的抗癌新药，已成为集新药研发、生产和商业化为一体的整合型生物医药公司。See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd. Investor Relations Phone Number： +86-10-67864938. Investor Relations Email：See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
Sep 30, 2024 Beijing Biostar successfully landed on the main board of the Hong Kong Stock Exchange, synthetic biology leads the new era of innovative drug research and development. 2024-09-30 Company News. Preliminary data released from a clinical study of Utidelone for the first-line treatment of advanced pancreatic cancer.See details»
Biostar Pharmaceuticals - Crunchbase Company Profile & Funding
Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China.See details»
Beijing Biostar Pharmaceuticals Company Description - Stock …
6 days ago Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.See details»
Beijing Biostar Pharmaceuticals Co. Ltd. - Drug pipelines ... - Patsnap
Nov 1, 2024 SAN FRANCISCO, Sept. 3, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that subject recruitment of a US Phase 1 clinical study …See details»
Biostar Pharma - News, Partnerships, Locations and Executives
Usearch identified 1 signals for Biostar Pharma, including: 1 Partnerships. Usearch has identified 1 executive & key decision-maker. Company . Services. Insights. Resources. Company. Schedule a Demo ... www.biostar-pharm.com: Professional, Scientific, and Technical Services (541) 1633 Bayshore Hwy Ste 280, Burlingame, California, 94010, United ...See details»
Beijing Biostar Pharmaceuticals Co. Ltd. - synapse.zhihuiya.com
了解Beijing Biostar Pharmaceuticals Co. Ltd. (北京华昊中天生物医药股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的24项临床试验, 83篇新闻和2篇文献，疾病领域:肿瘤，内分泌与代谢疾病，神经系统疾病，技术平台:化学药，小分子化药，药物:优替德隆，BG44，BG18，BG22，BGLP1。See details»
Biostar Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biostar Pharma, Inc. of Burlingame, CA. Get the latest business insights from Dun & Bradstreet.See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art synthetic biology technology platforms.See details»
Biostar Pharma - Overview, News & Similar companies - ZoomInfo
Jun 15, 2023 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer SAN FRANCISCO, March 21, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of …See details»
Beijing Biostar Pharmaceuticals. Information about the issuer.
Beijing Biostar Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells microbial fermentation microtubule inhibitor for cancer treatment field. Beijing Biostar Pharmaceuticals offers services worldwide.See details»
BIOSTAR PHARM-B Earnings Date, Reports & Earnings Call
Oct 29, 2024 02563 BIOSTAR PHARM-B Watchlist 0.000 0.000 0.00%; Trading Oct 29 09:30 CST ... Moomoo Financial Canada Inc. regulated by the Canadian Investment Regulatory Organization (CIRO) and Moomoo Securities Australia Ltd regulated by the Australian Securities and Investments Commission (ASIC). ...See details»
BIOSTAR PHARM-B (02563) Stock Price, News, Quotes-Moomoo
Oct 23, 2024 View BIOSTAR PHARM-B (02563) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the Moomoo stock trading app.See details»
Novotech and Biostar Establish Strategic Partnership Following …
Nov 12, 2024 Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing. Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech ...See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
Oct 30, 2024 Beijing Biostar Pharmaceuticals Co., Ltd. Access statement · Privacy policy · Terms of useSee details»
【风向标】国产抗肿瘤新药优替德隆注射液获FDA批准开展关键性II …
2024年7月5日， 北京华昊中天生物医药股份有限公司（下称“华昊中天”）美国子公司Biostar Pharma, Inc. 宣布，华昊中天自研的核心产品优替德隆注射液已获美国食品药品监督管理局（FDA）的批准，用于开展针对HER2- BCBM的临床研究—— “优替德隆注射液（UTD1）联合卡培他滨（CAP）治疗HER2- BCBM患者的 ...See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
October 31, 2024, Beijing Biostar Pharmaceuticals Co., Ltd. (“Biostar”, HKEX: 2563), which is a synthetic biology-driven biopharma company focusing on the development of patented innovative oncology drugs, today listed on the main board of Hong Kong Stock Exchange, making it the first public synthetic pharmaceutical company in Hong Kong.. At the listing ceremony, Dr Li Tang, …See details»
「华昊中天-B」首次递表港交所，投后估值45亿元 - 雪球
Jan 31, 2024 来源：招股书来源丨LiveReport大数据招股书丨点击文末“阅读原文”摘要：2024年1月29日，北京华昊中天 生物医药 股份有限公司 Beijing Biostar Pharmaceuticals Co., Ltd. (简称"华昊中天”)在港交所递交招股书，拟在香港IPO上市。公司是开发肿瘤创新药的全球化医药公 …See details»
Beijing Biostar Pharmaceuticals Co., Ltd.
Biostar is committed to the R&D of microbial metabolites innovative drugs, and has established advanced, unique and sustainable core technology platforms, including combinatorial biosynthesis, microbial fermentation production, microbial …See details»